Evidence map›Paper›PMID 40952267›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

The Proliferation of Osteosarcoma: The Impact of Phenol and Ethanol on Ki-67 Expressions.

Rhyan Darma Saputra, Mahardika Frityatama, Udi Heru Nefihancoro, Novan Adi Setyawan

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rhyan Darma SaputraOrthopedics & Traumatology Department, Faculty of Medicine, Sebelas Maret University, Moewardi General Hospital, Surakarta, Indonesia.
Mahardika FrityatamaResident of Orthopedics & Traumatology Specialist Programe, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia.ORCID 0009-0006-5239-1914
Udi Heru NefihancoroOrthopedics & Traumatology Department, Faculty of Medicine, Sebelas Maret University, Moewardi General Hospital, Surakarta, Indonesia.
Novan Adi SetyawanAnatomical Pathology Department, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteosarcoma is an aggressive primary bone malignancy characterized by a high rate of cellular proliferation, necessitating effective local control strategies. Ethanol and phenol have been utilized as adjuvant agents to inhibit tumor proliferation. However, comparative studies evaluating their efficacy in reducing osteosarcoma proliferation remain limited. This study aims to compare the effects of ethanol and phenol on reducing the proliferation of osteosarcoma, particularly in delineating tumor resection margins microscopically.

methodsThis experimental study was conducted at Dr. Moewardi General Hospital and the Anatomical Pathology Laboratory of the Faculty of Medicine, Sebelas Maret University, Surakarta from August to December 2024. Samples were obtained using purposive sampling. Osteosarcoma specimens were analyzed using immunohistochemistry to measure Ki-67 expression and divided into three treatment groups: ethanol, phenol, and NaCl (control). Statistical analyses included the Kruskal-Wallis test and Dunn's post hoc test to evaluate differences in Ki-67 expression among groups.

resultsA total of 22 osteosarcoma specimens were analyzed. The results demonstrated that both ethanol and phenol were effective as local control agents in reducing osteosarcoma proliferation, as measured by Ki-67 expression. Ethanol exhibited significantly greater efficacy compared to phenol and NaCl (p<0.05). The median Ki-67 expression levels were 5 (1-20) in the ethanol group, 10 (2-30) in the phenol group, and 20 (10-60) in the NaCl group.

conclusionBoth ethanol and phenol are effective as local control agents. However, ethanol demonstrates superior efficacy in reducing Ki-67 expression, establishing its potential as a more effective adjuvant in the management of osteosarcoma.

Indexed as

Bone NeoplasmsCell ProliferationEthanolKi-67 AntigenOsteosarcomaPhenolAdolescentAdultFemaleFollow-Up StudiesHumansMalePrognosisYoung AdultEthanolKi-67 AntigenPhenolKeywords: EthanolKi-67osteosarcomaPhenol

Identifiers

PMID40952267
PMCPMC12862403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.